MBMaria Cristina Bravo

Maria Cristina Bravo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Cristina Bravo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas Orfeo

    The University of Vermont, Department of Biochemistry, 360 South Park Drive, Colchester, VT, 05446, USA

    3 shared publications
  • Elizabeth M. Barker

    The University of Vermont, Department of Biochemistry, 360 South Park Drive, Colchester, VT, 05446, USA

    2 shared publications
  • Ira M. Bernstein

    The University of Vermont Medical Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, 111 Colchester Avenue, Burlington, VT, 05401, USA

    2 shared publications
  • Kelley C. McLean

    The University of Vermont Medical Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, 111 Colchester Avenue, Burlington, VT, 05401, USA

    2 shared publications
  • Matthew T. Gissel

    The University of Vermont, Department of Biochemistry, 360 South Park Drive, Colchester, VT, 05446, USA

    2 shared publications
  • A. Shapiro

    Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, United States of America

    1 shared publication

Latest Publications

  • Spontaneous clotting potential in the peripartum maternal circulation

    by Maria Cristina Bravo, Elizabeth M. Barker, Thomas Orfeo, Matthew T. Gissel, Ira M. Bernstein, Kelley C. McLean

  • Open Access

    Spontaneous Clotting Potential in the Peripartum Maternal Circulation

    by Maria Cristina Bravo, Elizabeth M. Barker, Thomas Orfeo, Matthew T. Gissel, Ira M. Bernstein, Kelley C. McLean

    IntroductionThe increased risk for thrombotic events during pregnancy and the peripartum period is well established. Our goal was to analyze the incidence and extent of endogenous clotting potential during the peripartum period that may contribute to the underlying mechanisms.METHODSA prospective longitudinal study enrolled women with uncomplicated pregnancies at 38-41 weeks gestation. Citrated platelet poor plasma was isolated at three visits (one 3rd trimester, and two postpartum). In this secondary retrospective analysis, aliquots were thawed and either centrifuged to remove sedimentable material or not, before being refrozen in advance of subsequent analysis. Exogenously and endogenously initiated coagulation assays were used to assess clot and thrombin formation (Thrombodynamics T2F analyzer and the calibrated automated thrombogram (CAT), respectively). Parameters describing exogenously initiated clot (ClotTF) and endogenously initiated clot (ClotSp) growth, and standard CAT parameters were collected. Comparisons were made across visits and between preparations using paired t-tests. Data are presented as mean ± standard deviation or Spearman correlation values.RESULTSClotSp growth was more robust at 18-48 hours postpartum compared to the late third trimester. Centrifugation removed all detectable ClotSp growth and reduced the speed of ClotTF growth. In exogenously initiated CAT assays, there were no significant differences across the immediate peripartum period. Depleted preparations had slightly slower dynamics compared to control preparations. We observed a correlation between the rates of ClotSp and ClotTF growth.CONCLUSIONThrough 18-48 hours after delivery there is an increase in endogenous clotting potential compared to late pregnancy, centrifugation of this sedimentable material removes most of this endogenous activity.

  • Characterization of the Endothelial, Coagulofibrinolytic, and Inflammatory Profile in Burn Patients after Resuscitation with Fresh Frozen Plasma

    by Amanda M Soo Ping Chow, Anthony E Pusateri, Tuan D Le, Thomas Orfeo, Matthew Gissel, Maria Cristina Bravo, Melissa McLawhorn, Lauren T Moffatt, Jeffrey W Shupp

    Severe burn injuries are associated with endothelial, coagulopathic, and inflammatory dysfunction, requiring resuscitation; this is most often performed with intravenous crystalloids. Colloids, like fresh frozen plasma (FFP), can be used as adjuncts. This prospective observational cohort study investigated whether the varying factor and protein concentrations in a unit of FFP, as well as its allogenic nature, affected the preexisting prothrombotic, fibrinolytic, and hyperinflammatory state in burn shock in a group of patients with ≥20% total body surface area (TBSA) who receive transfused plasma as part of the standard of care for resuscitation at a regional burn center. Blood samples were collected immediately prior to administration of the first unit of FFP (Pre-Unit) and immediately after administration of the first unit of FFP (Post-Unit). Concentrations of 31 plasma biomarkers were quantified and compared using a paired t-test or a Wilcoxon signed-rank test. Data presented as median (interquartile range). Of the 33 patients included, the median TBSA burn was 34.0% (27.3-45.5). Post-Unit plasma concentrations were decreased compared to Pre-Unit concentrations in factor VIII (329 [201.9-474.1] vs 277 [189.5-438.1] %), fibrinogen (322 [295.3-412.8] vs 305 [285.3-388.5] mg/dL), protein C (105 [96.0-111.5] vs 102 [91.5-112.0] %), total tissue factor pathway inhibitor (TFPI) (69.7 [51.1-96.3] vs 67.7 [50.9-84.5] ng/mL), free TFPI (18.2 [14.2-21.8] vs 16.8 [12.9-21.1] ng/mL), activated/inactivated thrombin-activatable fibrinolysis inhibitor (55.1 [40.7-80.4] vs 48.7 [38.4-64.4] ng/mL), C1 esterase inhibitor (149.6 [132.3-222.1] vs 119.6 [110.4-151.6] %), and TNF-α receptor 1 (2010 [1451-3535] vs 1815 [1418-3189] pg/mL) (P ≤ .05). The 23 other biomarkers did not change. While there were small but statistically significant reductions in 8 markers of coagulation, antifibrinolysis, and inflammation, the Post-Unit concentrations either remained within or moved closer to the expected reference ranges. After the initial transfusion of FFP, there were no clinically significant changes in the preexisting prothrombotic, fibrinolytic, endothelial, or inflammatory biological profile.

  • Prior preterm preeclampsia and hemostatic balance in the non-pregnant state

    by Christine E. Horn, Maria Cristina Bravo, Thomas Orfeo, Kelley McLean, Ira Bernstein

  • Open Access

    Placental Maternal Vascular Malperfusion Is Associated with Prepregnancy and Early Pregnancy Maternal Cardiovascular and Thrombotic Profiles

    by Carole A. McBride, Ira M. Bernstein, Amelia B. Sybenga, Kelley C. McLean, Thomas Orfeo, Maria Cristina Bravo

    Characteristics of maternal vascular malperfusion (MVM) are frequently observed in placentas from pregnancies impacted by preeclampsia, intrauterine growth restriction, preterm labor, and intrauterine fetal demise. We sought to evaluate the associations of features of MVM with subclinical measures of cardiovascular health and coagulation potential in healthy young women. Sixty-three healthy young women were recruited and assessed prior to pregnancy on cycle day 9 ± 4, at gestational age 90 ± 6 of early pregnancy, and gestational age 216 ± 5 of late pregnancy. Women were assessed for plasma volume, blood pressure, response to volume loading, cardiac output, and uterine hemodynamics. Platelet-poor plasma was collected to assess thrombin generation on a subset of 33 women at all time points. Following delivery, placentas were collected and analyzed for evidence of MVM. Thrombin generation (TG) was evaluated in the presence of tissue factor (TF) with and without recombinant soluble thrombomodulin (TM). For each, we compared TG lagtime, peak level, and endogenous thrombin potential (ETP). Comparisons were made between dichotomized presence and absence of each individual feature of MVM and cardiovascular and coagulation features. Mean ± standard deviation are presented. Women were 31 ± 4 years of age, body mass index of 24 ± 5 kg/m2, 86% white race, and 80% nulliparous. MVM occurred in 70% of placentas, with infarcts and agglutination (44%), decidual arteriopathy (40%), accelerated villous maturation (32%), placental hypoplasia (29%), and distal villous hypoplasia (17%) documented. Decidual arteriopathy and distal villous hypoplasia were associated with prepregnancy maternal physiology, including decreased plasma volume and subclinical cardiovascular variations. All assessed MVM characteristics had identifiable early pregnancy physiologic characteristics consistent with altered cardiovascular function and decreased uterine response to pregnancy when compared with women who did and did not develop MVM. Accelerated villous maturation was the only MVM feature to differ by thrombin generation parameters in early pregnancy. Thrombin generation potential and blood pressure were elevated in late pregnancy in women who developed decidual arteriopathy. Prepregnancy health status and adaptation to pregnancy play important roles in pregnancy outcomes. Both cardiovascular health and thrombin generation potential may influence early placentation. Longitudinal assessment of subclinical maternal factors may allow for better understanding of the etiologies of MVM lesions, as well as allow for identification of a timeline of the origins of placental pathologies.


  • Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls

    by S. Gupta, M.C. Bravo, M. Heiman, C. Nakar, K. Brummel-Ziedins, C.H. Miller, A. Shapiro